Novo Nordisk (NVO) cash on hand

Cash · fiscal 2025
DKK 26.96B

Novo Nordisk (NVO) held cash of DKK 26.96B at the end of fiscal 2025 (December 31, 2025). That is 2.5% higher than the DKK 26.31B of fiscal 2024. Figures as of 18 Nov 2026, 06:56 UTC, from Yahoo Finance.

Key facts

Cash, fiscal 2025
DKK 26.96B
Change on fiscal 2024
+2.5%
Highest on record
DKK 30.23Bfiscal 2023
Lowest on record
DKK 23.57Bfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in DKK. Figures, not advice.

Novo Nordisk cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was DKK 30.23B in fiscal 2023 and the lowest DKK 23.57B in fiscal 2022.

History · 4 fiscal years

Cash by fiscal year

Novo Nordisk cash on hand, year by year

Novo Nordisk (NVO) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025DKK 26.96B 2.5% up
2024DKK 26.31B 13.0% down
2023DKK 30.23B 28.2% up
2022DKK 23.57B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Novo Nordisk and comparable companies
CompanyCashFiscal year
Gilead Sciences GILD$9.61B2025
Abbott Laboratories ABT$8.94B2025
Novo Nordisk NVODKK 26.96B2025
Pfizer PFE$13.60B2025
Danaher DHR$4.62B2025
Intuitive Surgical ISRG$5.93B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NVO

Novo Nordisk, figure by figure

Novo Nordisk (NVO) overview: price, valuation and scorecardAll health care companies by market value

Novo Nordisk cash on hand: questions and answers

How much cash does Novo Nordisk have?

Novo Nordisk (NVO) held cash of DKK 26.96B at the end of fiscal 2025 (December 31, 2025). That is 2.5% higher than the DKK 26.31B of fiscal 2024.

What are the highest and lowest cash figures on record for Novo Nordisk?

Across the 4 fiscal years on record (2022–2025), the highest was DKK 30.23B in fiscal 2023 and the lowest DKK 23.57B in fiscal 2022.

How is Novo Nordisk's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novo Nordisk (NVO) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/NVO/cash

Underlying data: Yahoo Finance.